2016 International Congress

Tuesday, June 21, 2016

12:30pm-2:00pm

Persistent myoclonic dystonia due to SCL2A1 mutation

P.H. McNamara, D. Olszewska, A. McCarthy, J. McKinley, T. McVeigh, T. Lynch (Dublin, Ireland)

Myoclonus  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Pharmacokinetic-pharmacodynamic effects of apomorphine sublingual film (APL-130277) for the rapid management of OFF episodes in patients with Parkinson’s disease

E.J. Pappert, B. Dzyngel, T. Bilbault, A. Agro (Toronto, ON, Canada)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Phenotype and genotype variability of CACNA1A in a cohort of ataxia in Taiwan

P.Y. Fong, T.H. Yeh, S.C. Lai, C.S. Lu (Taoyuan City, Taiwan)

Genetics (NON-PD)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Phenotypes in Essential Tremor: Gait analysis and imaging study

E. Boutin, T. Witjas, R. Carron, J. Regis, E. Guedj, J.P. Azulay, M. Vaugoyeau (Marseille, France)

Tremor  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Phenotypic characteristics in GBA-associated Parkinson’s disease (PD): A study in a Greek population

A.M. Simitsi, C. Koros, N. Papagiannakis, R. Antonelou, M. Moraitou, H. Michelakakis, M. Stamelou, L. Stefanis (Athens, Greece)

Parkinson's disease: Genetics  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Phosphorylation by GSK-3β enhances binding of metal ion induced tau oligomers to neutral lipid surfaces

G.S. Nuebling, E. Plesch, T. Högen, S. Lorenzl, F. Kamp, A. Giese (Munich, Germany)

Pathophysiology (other movement disorders)  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Physical training prevents depressive-like behavior and bdnf decrease in an animal model of Parkinson’s disease

T. Tuon, S.S. Valvasori, J.L. Quevedo, C.T. Souza, R.A. Pinho (Criciúma, Brazil)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

PINK1-dependent clearance of depolarized mitochondria is driven by the UPS and can occur independently of (macro)autophagy

A. Rakovic, J. Ziegler, C.U. Mårtensson, J. Prasuhn, K. Shurkewitsch, P. König, H.L. Paulson, C. Klein (Luebeck, Germany)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Piper longum L. alkaloids inhibit lipopolysaccharide-stimulated microglial activation and protect nigral dopaminergic neurons

H. Yang, C. Duan (Beijing, People's Republic of China)

Parkinson's disease: Pathophysiology  ·  Exhibit Hall located in Hall B, Level 2

12:30pm-2:00pm

Polyethylenimine (PEI) nanoparticle-mediated delivery of siRNA to silence neuronal gene expression of alpha-synuclein in a mouse model of Parkinson’s disease

C. Helmschrodt, A. Bauer, S. Höbel, S. Schöniger, S.A. Fietz, A. Aigner, A. Richter, F. Richter (Leipzig, Germany)

Therapy in movement disorders: Gene and cell-based therapies  ·  Exhibit Hall located in Hall B, Level 2